SARS-CoV-2 3CLpro-IN-6
SARS-CoV-2 3CLpro-IN-6 is a reversible covalent inhibitor of SARS-CoV-2 3CL protease. SARS-CoV-2 3CLpro-IN-6 has potent inhibitory activity for SARS-CoV-2 3CLpro with an IC50 value of 4.9 μM. SARS-CoV-2 3CLpro-IN-6 can be used for the research of coronavirus disease 2019 (COVID-19) [1].
Product Specifications
CAS Number
302821-53-0
UNSPSC
12352005
Target
SARS-CoV
Type
Reference compound
Related Pathways
Anti-infection
Applications
COVID-19-anti-virus
Field of Research
Infection
Assay Protocol
https://www.medchemexpress.com/sars-cov-2-3clpro-in-6.html
Solubility
10 mM in DMSO
Smiles
COC(C(/C(C(C1=CC=CC=C1)=O)=C\C2=CC=C(O2)C3=C(C=CC=C3)[N+]([O-])=O)=O)=O
Molecular Formula
C22H15NO7
Molecular Weight
405.36
References & Citations
[1]Liying Wang, et al. Discovery of novel SARS-CoV-2 3CL protease covalent inhibitors using deep learning-based screen. Eur J Med Chem. 2022 Dec 15;244:114803.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
E45M48754M5 20 µg
1110059G10Rik (NM_025419) Mouse Recombinant Protein
Sign In for Pricing
View Details 
